Synairgen's Drug Shows Reduced Risk of Severe Disease in Covid-19 Patients

The trial, which used interferon beta, showed that patients who were given Synairgen's formulation had a 79% lower risk of developing severe disease compared to placebo.

from Top India News- News18.com https://ift.tt/3hgJ4Bl